Rice Hall James & Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-22,628
| Closed | -$912K | – | 309 |
|
|
2018
Q4 | $912K | Buy |
22,628
+2,101
| +10% | +$84.7K | 0.03% | 249 |
|
|
2018
Q3 | $1.42M | Sell |
20,527
-14,932
| -42% | -$1.04M | 0.05% | 229 |
|
|
2018
Q2 | $2.68M | Buy |
35,459
+14,452
| +69% | +$1.09M | 0.1% | 145 |
|
|
2018
Q1 | $1.11M | Buy |
+21,007
| New | +$1.11M | 0.04% | 238 |
|
|
2017
Q3 | – | Sell |
-201,904
| Closed | -$15.9M | – | 301 |
|
|
2017
Q2 | $15.9M | Buy |
201,904
+71,185
| +54% | +$5.62M | 0.69% | 69 |
|
|
2017
Q1 | $10.8M | Buy |
+130,719
| New | +$10.8M | 0.53% | 80 |
|